- Home
- BEAM vs CASH Comparison
BEAM vs CASH Comparison
Compare BEAM & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAM
- CASH
- Stock Information
- Founded
- BEAM 2017
- CASH 1954
- Country
- BEAM United States
- CASH United States
- Employees
- BEAM N/A
- CASH N/A
- Industry
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- CASH Major Banks
- Sector
- BEAM Health Care
- CASH Finance
- Exchange
- BEAM Nasdaq
- CASH Nasdaq
- Market Cap
- BEAM 2.3B
- CASH 1.9B
- IPO Year
- BEAM 2020
- CASH N/A
- Fundamental
- Price
- BEAM $30.43
- CASH $77.49
- Analyst Decision
- BEAM Buy
- CASH Hold
- Analyst Count
- BEAM 10
- CASH 3
- Target Price
- BEAM $48.75
- CASH $79.67
- AVG Volume (30 Days)
- BEAM 1.2M
- CASH 175.1K
- Earning Date
- BEAM 03-04-2025
- CASH 01-21-2025
- Dividend Yield
- BEAM N/A
- CASH 0.26%
- EPS Growth
- BEAM N/A
- CASH 12.58
- EPS
- BEAM N/A
- CASH 6.88
- Revenue
- BEAM $349,643,000.00
- CASH $719,617,000.00
- Revenue This Year
- BEAM N/A
- CASH N/A
- Revenue Next Year
- BEAM $14.62
- CASH $5.72
- P/E Ratio
- BEAM N/A
- CASH $11.31
- Revenue Growth
- BEAM 328.73
- CASH 9.58
- 52 Week Low
- BEAM $20.84
- CASH $46.68
- 52 Week High
- BEAM $49.50
- CASH $86.00
- Technical
- Relative Strength Index (RSI)
- BEAM 57.12
- CASH 44.38
- Support Level
- BEAM $25.35
- CASH $78.49
- Resistance Level
- BEAM $35.25
- CASH $81.64
- Average True Range (ATR)
- BEAM 2.10
- CASH 2.19
- MACD
- BEAM 0.56
- CASH -0.25
- Stochastic Oscillator
- BEAM 55.88
- CASH 23.18
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
About CASH Pathward Financial Inc.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.